.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
Ponseti treatment achieves high initial correction rates in idiopathic clubfoot, but relapse remains one of the central long-term challenges. This systematic analysis pooled data from multiple studies to examine relapse over prolonged follow-up after Ponseti correction and standard bracing. Across more than 2,000 patients, relapse occurred in roughly one-third of feet, illustrating why successful early correction should not be equated with permanent cure. The analysis also found that relapse could continue to appear beyond the first few years, reinforcing the need for prolonged surveillance rather than assuming that risk disappears once walking begins. The clinical message is especially important for counselling families: recurrence is not necessarily a sign that the initial treatment failed, and it can often be managed successfully when detected early. Brace adherence remains a major modifiable factor, making caregiver education and practical support central to care. For HCPs, the study supports structured follow-up into the later childhood years, attention to dynamic supination or recurrent equinus, and prompt re-casting when needed. The paper reinforces the principle that the long-term success of Ponseti depends as much on sustained follow-up and family engagement as on the initial correction.
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
Ponseti treatment achieves high initial correction rates in idiopathic clubfoot, but relapse remains one of the central long-term challenges. This systematic analysis pooled data from multiple studies to examine relapse over prolonged follow-up after Ponseti correction and standard bracing. Across more than 2,000 patients, relapse occurred in roughly one-third of feet, illustrating why successful early correction should not be equated with permanent cure. The analysis also found that relapse could continue to appear beyond the first few years, reinforcing the need for prolonged surveillance rather than assuming that risk disappears once walking begins. The clinical message is especially important for counselling families: recurrence is not necessarily a sign that the initial treatment failed, and it can often be managed successfully when detected early. Brace adherence remains a major modifiable factor, making caregiver education and practical support central to care. For HCPs, the study supports structured follow-up into the later childhood years, attention to dynamic supination or recurrent equinus, and prompt re-casting when needed. The paper reinforces the principle that the long-term success of Ponseti depends as much on sustained follow-up and family engagement as on the initial correction.
Today
The phase 3 ACACIA-HCM trial reveals that aficamten improves cardiac structure, diastolic relaxation, functional capacity, and symptom burden in symptomatic nonobstructive hypertrophic cardiomyopathy, marking a major milestone in targeted myosin inhibition.
6 days back
A clinical study shows that automated breast ultrasound paired with artificial intelligence accurately classifies BIRADS 3-4 lesions, reaching 95% sensitivity and 79% specificity. This diagnostic advance promises to reduce unnecessary core needle biopsies and refine clinical workflows in breast imaging.
3 weeks back
Researchers have engineered freestanding hierarchical-porous BCZT thin films that resist cracking and enhance ultrasonic energy harvesting in soft tissue. Achieving high piezoelectric output and acoustic matching, this lead-free material offers transformative potential for implantable bioelectronics.
6 days back
A novel pathology-adaptive surface engineering strategy uses functionalized plasma polymer coatings to selectively modulate AGE adsorption, reducing oxidative stress and restoring bone formation in diabetic and aging microenvironments.
3 weeks back
A breakthrough study identifies the Klotho/PKCα/CUX1/SPARC/TGFβ-RII axis as a critical driver of podocyte mitochondrial injury and ferroptosis in diabetic kidney disease, unveiling promising molecular targets to halt renal disease progression.
6 days back
